Acupuncture to help safely reduce antidepressant dose
Part of Mental health clinical trials.
This study tests whether adding intradermal acupuncture (tiny needles placed just under the skin) can help people with depression safely reduce their antidepressant medication without symptoms coming back. It may offer a supportive way to taper off medication under medical supervision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with major depressive disorder and are currently stable (no current major depressive episode for the last 3 months).
- You have been taking an SSRI antidepressant (like sertraline, fluoxetine, or escitalopram) for at least 6 months, with the same dose for the last 4 weeks.
- You and your doctor agree that it is safe to slowly reduce your antidepressant dose.
- You are not pregnant or breastfeeding, and you do not have bleeding disorders or allergies to adhesive tape.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans (MRI) to see how acupuncture may quickly improve depression symptoms. If you are currently being treated for depression with moderate symptoms, you may join and help researchers learn if acupuncture could be a helpful option.
This trial tests whether low-dose laser acupuncture can help improve sleep in people with major depression. If you have depression and trouble sleeping, this treatment might offer a non-drug option to improve your rest.
This study tests whether esketamine, a nasal spray for depression, can help adults whose depression has not improved with at least two other antidepressants. Participants continue their current treatment while receiving esketamine.
This trial tests how treatment with esketamine affects metabolism in people with depression. It may help if you have not responded to at least two standard antidepressants.
This trial tests a new medication called ABX-002 as an add-on to your current antidepressant. It's for people with moderate to severe depression who haven't gotten enough help from their current antidepressant alone.
This study tests whether adding acupuncture to a common antidepressant (escitalopram) helps improve depression symptoms more than the medication alone. It aims to see if this combination can be a safe and effective treatment for adults with major depression.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.